K213422

Substantially Equivalent

EkoSonic Endovascular Device, EKOS+ Endovascular Device

Applicant: Boston Scientific Corporation
Product code: QEY
Advisory panel: Cardiovascular
Date received: 2021-10-20
Decision date: 2021-12-14
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Maple Grove, MN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.